CO5690618A2 - THERAPEUTIC AGENT FOR MESOTELIOMA - Google Patents

THERAPEUTIC AGENT FOR MESOTELIOMA

Info

Publication number
CO5690618A2
CO5690618A2 CO06044336A CO06044336A CO5690618A2 CO 5690618 A2 CO5690618 A2 CO 5690618A2 CO 06044336 A CO06044336 A CO 06044336A CO 06044336 A CO06044336 A CO 06044336A CO 5690618 A2 CO5690618 A2 CO 5690618A2
Authority
CO
Colombia
Prior art keywords
mesothelioma
therapeutic agent
antibody
receptor
mesotelioma
Prior art date
Application number
CO06044336A
Other languages
Spanish (es)
Inventor
Norihiro Nishimoto
Tadamitsu Kishimoto
Yasuo Adachi
Koichi Takayama
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CO5690618A2 publication Critical patent/CO5690618A2/en

Links

Abstract

1.- Un agente terapéutico para el mesotelioma que contiene un antagonista de la interleuquina-6 (IL-6) como su ingrediente activo.2.- Un agente terapéutico para el mesotelioma de acuerdo con la reivindicación 1 en la cual el mesotelioma es el mesotelioma de pleura.3.- Un agente terapéutico para el mesotelioma de acuerdo con la reivindicación 2 en la cual el mesotelioma de pleura es el mesotelioma de pleura maligno.4.- Un agente terapéutico para el mesotelioma de acuerdo con cualquiera de las reivindicaciones 1 a 3 en las cuales el antagonista de IL-6 es el anticuerpo para el receptor de IL-6.5.- Un agente terapéutico para el mesotelioma de acuerdo con la reivindicación 4 en la cual el anticuerpo para el receptor de IL-6 es el anticuerpo monoclonal para el receptor de IL-6.6.- Un agente terapéutico para el mesotelioma de acuerdo con la reivindicación 4 en la cual el anticuerpo para el receptor de IL-6 es el anticuerpo monoclonal para el receptor de IL-6 humano.7.- Un agente terapéutico para el mesotelioma de acuerdo con la reivindicación 4 en la cual el anticuerpo para el receptor de IL-6 es el anticuerpo monocional para el receptor de IL-6 de ratón.8.- Un agente terapéutico para el mesotelioma de acuerdo con cualquiera de las reivindicaciones 4 a 7 en las cuales el anticuerpo para el receptor de IL-6 es el anticuerpo recombinante.1. A therapeutic agent for mesothelioma containing an interleukin-6 antagonist (IL-6) as its active ingredient. 2. A therapeutic agent for mesothelioma according to claim 1 wherein the mesothelioma is the Pleura mesothelioma. 3. A therapeutic agent for mesothelioma according to claim 2 wherein the pleura mesothelioma is malignant pleural mesothelioma. 4. A therapeutic agent for mesothelioma according to any of claims 1. to 3 in which the IL-6 antagonist is the antibody for the IL-6.5 receptor. - A therapeutic agent for mesothelioma according to claim 4 in which the antibody for the IL-6 receptor is the antibody. monoclonal for the IL-6.6 receptor. A therapeutic agent for mesothelioma according to claim 4 wherein the antibody for the IL-6 receptor is the monoclonal antibody for the human IL-6 receptor. An agent for mesothelioma according to claim 4, in which the antibody for the IL-6 receptor is the monoclonal antibody for the mouse IL-6 receptor. 8 .- A therapeutic agent for mesothelioma according to any of claims 4 to 7 in which the antibody for the IL-6 receptor is the recombinant antibody.

CO06044336A 2003-10-17 2006-05-10 THERAPEUTIC AGENT FOR MESOTELIOMA CO5690618A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003358162A JP2004094966A (en) 2003-10-17 2003-10-17 Computer and computer system

Publications (1)

Publication Number Publication Date
CO5690618A2 true CO5690618A2 (en) 2006-10-31

Family

ID=32064633

Family Applications (1)

Application Number Title Priority Date Filing Date
CO06044336A CO5690618A2 (en) 2003-10-17 2006-05-10 THERAPEUTIC AGENT FOR MESOTELIOMA

Country Status (2)

Country Link
JP (1) JP2004094966A (en)
CO (1) CO5690618A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4910604B2 (en) * 2006-09-28 2012-04-04 富士電機株式会社 Slave device
JP4852070B2 (en) * 2008-06-16 2012-01-11 三菱電機株式会社 Plant monitoring and control system
US8762994B2 (en) * 2010-08-26 2014-06-24 Intel Corporation Power-optimized interrupt delivery

Also Published As

Publication number Publication date
JP2004094966A (en) 2004-03-25

Similar Documents

Publication Publication Date Title
BR0208636A (en) Therapeutic agent for chronic arthritic diseases of childhood-related diseases
BRPI0415505A (en) mesothelioma therapeutic agent
BRPI0417072A (en) preventive agent for vasculitis
ATE556060T1 (en) MONOCYCLIC ANILIDE SPIROHYDANTOINS AS CGRP RECEPTOR ANTAGONISTS
MY146986A (en) Methods for treating interleukin-6 related diseases
CL2008001659A1 (en) Quinoxaline derived compounds as inhibitors of the tyrosine kinase activity of janus kinases; pharmaceutical composition comprising said compounds; and its use to treat an immunological disease selected from organ transplant rejection, lupus, multiple sclerosis, among other diseases.
TNSN07005A1 (en) TETRAPEPTITIIC ANALOGS
BRPI0817482B8 (en) use of an interleukin-6 (il-6) receptor antibody in the treatment of graft versus host disease (gvhd)
DE602004013563D1 (en) RANTAGONISTEN
UY27793A1 (en) PIRAZOLOPIRIDINS SUBSTITUTED WITH CARBAMATE
CO5011096A1 (en) MEDICINES CONTAINING ANTAGONISTS OF THE 5-HT3 RECEPTOR FOR THE TREATMENT OF IBS
AR037109A1 (en) USE OF FLIBANSERINE
NO20073182L (en) Indazol-carboxamide
CL2021002503A1 (en) Anti-tryptase antibodies, compositions of these and uses of these. (request divisional 201902251)
DE602005016446D1 (en) 5-HT4 receptor agonist compounds
ATE431824T1 (en) QUINOLINONE-CARBOXAMIDE COMPOUNDS
AR049876A1 (en) PHARMACEUTICAL COMPOSITIONS TO TREAT SKIN DISEASES THAT INCLUDE A COMBINATION OF EPINASTINE AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE GROSS PHARMACOS
NO20024646D0 (en) Combination therapies with vasculature-damaging activity
AR030554A1 (en) SIMILAR MOLECULES TO IL-17 RECEPTORS AND USES OF THE SAME
CR6824A (en) ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRIPTASE INHIBITORS
CO5690618A2 (en) THERAPEUTIC AGENT FOR MESOTELIOMA
ES2195010T3 (en) DERIVATIVES OF DI-ARILALQUENILAMINAS.
ECSP055917A (en) DERIVATIVES OF USEFUL DIAZEPANES AS LFA INHIBITORS
UY26945A1 (en) PHENOXYPHENYL ALCANOSULPHONATES
SE0001631D0 (en) New use